Lactatrim MC Lactating Cow Intramammary Suspension.

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

קנה את זה

הורד מאפייני מוצר (SPC)
12-06-2017

מרכיב פעיל:

Trimethoprim; Sulphadiazine

זמין מ:

Norbrook Laboratories Limited

קוד ATC:

QJ51E

INN (שם בינלאומי):

Trimethoprim; Sulphadiazine

כמות:

40/200 mg/syringe

טופס פרצבטיות:

Intramammary suspension

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

קבוצה תרפויטית:

Cattle

איזור תרפויטי:

SULFONAMIDES AND TRIMETHOPRIM FOR INTRAMAMMARY USE

סממני תרפויטית:

Antibacterial

מצב אישור:

Authorised

תאריך אישור:

1996-10-18

מאפייני מוצר

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Lactatrim MC Lactating Cow Intramammary Suspension.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH 8 G SYRINGE CONTAINS:
Active substances
Trimethoprim 40 mg
Sulphadiazine 200 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Intramammary suspension.
A white to off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (Lactating)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The veterinary medicinal product is an intramammary suspension for the
broad spectrum treatment of clinical mastitis in lactating
cattle caused by organisms sensitive to the Trimethoprim/Sulphadiazine
combination.
Clinically, the veterinary medicinal product has been shown to be
effective in the routine treatment of mastitis in lactating cows.
The veterinary medicinal product exerts a bactericidal activity at
concentrations attained in the udder.
_In vitro_ the veterinary medicinal
product
is effective against gram-positive and gram-negative bacteria
including_ Streptococcus_
_agalactiae_,
_Streptococcus_
_dysgalactiae_,
_Streptococcus_
_uberis_
and
other
streptococcal
species,
staphylococcal
spp.,
_Corynebacterium pyogenes_,_ Eschericha coli_, and other gram-negative
bacteria.
4.3 CONTRAINDICATIONS
Do not use in cattle with known sulphonamide sensitivity, with hepatic
damage or with blood dyscrasias.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_
_0_
_9_
                                
                                קרא את המסמך השלם
                                
                            

חיפוש התראות הקשורות למוצר זה